Millions could meet criteria to receive GLP-1s, which could cost Medicare billions of dollars, according to a report by KFF.

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...

A new Medicare pilot program aims to expand access to GLP-1 weight loss medications, potentially reducing out-of-pocket costs ...

For years, GLP-1 medication has transformed conversations around weight loss but left many virtually locked out by costs. Now ...

Starting this week, the federal government is offering a selection of the brand name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called ...

Millions of Americans are expected to gain coverage for GLP-1 drugs for weight loss under a new U.S. pilot launching on ...

The drugs covered under the program include Wegovy tablets and injections, Zepbound KwikPens, and Foundayo tablets ...

Does Medicare pay for GLP-1 drugs like Ozempic for weight loss? For years, the answer has been a hard no. But a new “Bridge” ...

Medicare will start the GLP-1 Bridge program July 1. Older adults who qualify for the weight-loss drugs will pay a monthly ...

Medicare’s new GLP-1 bridge program will provide eligible Part D prescription plan enrollees inexpensive monthly copays for ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

You might have heard about medications like Ozempic®, Mounjaro®, and metformin for weight loss. But these drugs are actually diabetes medications that are sometimes prescribed off-label for weight ...